等待开盘 09-26 09:30:00 美东时间
+6.450
+2.31%
Onto Innovation (NYSE:ONTO) has outperformed the market over the past 10 years by 15.6% on an annualized basis producing an average annual return of 29.23%. Currently, Onto Innovation has a market capitalization of $17.35 billion. Buying $1000 In ONTO: If an investor had bought $1000 of ONTO stock 1...
09-23 04:45
今日重点评级关注:Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.3美元升至8.45美元;摩根大通:维持Vera Therapeutics"超配"评级,目标价从76美元升至83美元
09-09 15:36
Onto Innovation (NYSE:ONTO) has outperformed the market over the past 10 years by 13.99% on an annualized basis producing an average annual return of 27.37%. Currently, Onto Innovation has a market capitalization of $15.43 billion. Buying $1000 In ONTO: If an investor had bought $1000 of ONTO stock ...
09-03 22:15
Bloom Energy大升5.52%;Moderna上升3.97%;Onto Innovation上升3.64%
08-25 16:11
今日重点评级关注:Canaccord Genuity:维持Cardiol Therapeutics"买入"评级,目标价从8美元升至10美元;B. Riley证券:维持Macrogenics"买入"评级,目标价从9美元升至11美元
08-18 11:39
Goldman Sachs analyst James Schneider initiates coverage on Onto Innovation (NYSE:ONTO) with a Buy rating and announces Price Target of $400.
08-17 17:19
• 受强劲的检测与量测平台需求推动,Onto Innovation 业绩超出预期。 • 公司在手订单创下历史新高,毛利率和营业利润率双双提升。 • 分析师纷纷上调其评级,平均目标价为 367.47 美元。
08-11 18:16
Onto Innovation ( ($ONTO) ) just unveiled an update. On August 10, 2026, Onto I...
08-10 20:59
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24